The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2024

Filed:

Aug. 15, 2017
Applicants:

Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);

University of Hawaii, Honolulu, HI (US);

Inventors:

Robert A. Nichols, Honolulu, HI (US);

Kelly Forest, Honolulu, HI (US);

Victor J. Hruby, Tucson, AZ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); A61K 9/00 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61P 25/28 (2006.01); C07K 14/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4711 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 38/00 (2013.01); A61K 38/1716 (2013.01); A61P 25/28 (2018.01); C07K 14/00 (2013.01);
Abstract

Peptide analogues of β-amyloid and methods of using said analogues for neuroprotection are described herein. The β-amyloid peptide analogues have a sequence that is at least 50% identical to an N-terminal β-amyloid core fragment. A pharmaceutical composition of the β-amyloid peptide analogues in a pharmaceutically acceptable carrier can be administered to a subject for neuromodulation. The β-amyloid peptide analogues, while lacking neurotoxicity, effectively provides for protective activity against β-amyloid toxicity.


Find Patent Forward Citations

Loading…